Dr. Scott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
505 Parnassus Ave
Rm M-987
San Francisco, CA 94143Phone+1 415-476-1528Fax+1 415-502-1976
Education & Training
University of California (San Francisco)Fellowship, Infectious Disease, 2010 - 2012- University of California (San Francisco)Residency, Internal Medicine, 2006 - 2010
Yale School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2025- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Personalized HIV and STI Testing Tool Start of enrollment: 2019 Sep 18
- HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing Start of enrollment: 2017 Jan 09
Publications & Presentations
PubMed
- Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative exploration.Jennifer Velloza, Albert Y Liu, Ariana W K Katz, Ariane van der Straten, Aaron J Siegler
AIDS Care. 2024-11-01 - Point-of-care urine tenofovir test predicts future HIV preexposure prophylaxis discontinuation among young users.Tyler Martinson, Rikki Montoya, Carlos Moreira, Karen Kuncze, Kevin Sassaman
AIDS. 2024-09-01 - Protein Dose-Sparing Effect of AS01B Adjuvant in a Randomized Preventive HIV Vaccine Trial of ALVAC-HIV (vCP2438) and Adjuvanted Bivalent Subtype C gp120.Zvavahera Mike Chirenje, Fatima Laher, One Dintwe, Monde Muyoyeta, Allan C deCamp
The Journal of Infectious Diseases. 2024-08-16
Press Mentions
CROI 2023: Dr. Dieffenbach Shares Research Highlights on Long-Acting HIV Prevention and Treatment, COVID, and a Cure UpdateFebruary 22nd, 2023- ‘Here We Go Again’: Amid HIV/AIDS Connection, Fear of Racial Disparities for MPX GrowsSeptember 6th, 2022
- Test of a New 'Germline-Targeting' HIV Vaccine Prepares to LaunchMay 19th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
